Marksans Pharma Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has submitted a quarterly compliance certificate from its Registrar and Transfer Agent, Bigshare Services Pvt Ltd, for the quarter ended June 30, 2025. The certificate confirms that all physical share certificates received from depository participants for demat (dematerialization) during the quarter were properly verified, confirmed, and processed. The original certificates were cancelled, and the depositories' names were entered in the company's register of members within 15 days as required by SEBI rules. This is a standard procedural filing required every quarter under SEBI's Depositories Regulations.
This is a routine regulatory compliance filing with no material impact on the company's business, financials, or shareholders. Investors should view it as normal housekeeping and not expect any effect on the stock price.